Payment overview · 2025
General Payments
$78.45
5 reported records · 4 companies
Healthcare provider profile · identity verified
Ronald Mark Varner, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · EL DORADO, KS · NPI 1578693735
Verified facts
What the public records show
CMS Open Payments records show Ronald Mark Varner, D.O. received $78.45 in general payments during 2025 across 5 reported records.
Amgen Inc. accounted for 42.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $33.58 | 42.8% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $16.27 | 20.7% | 1 | 2025 |
| PROTEGA PHARMACEUTIALS INC | Unresolved — no canonical attribution shown | $14.89 | 19.0% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $13.71 | 17.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $78.45 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $33.58 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $33.58 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $16.27 | 1 | 2025 |
Source payment records
|
|||||
| ROXYBOND Normalized: roxybond |
Drug | PROTEGA PHARMACEUTIALS INC | $14.89 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $13.71 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1001 | 92 |
| Atorvastatin Calcium | Atorvastatin Calcium | 620 | 152 |
| Levothyroxine Sodium | Levothyroxine Sodium | 603 | 117 |
| Losartan Potassium | Losartan Potassium | 557 | 127 |
| Pantoprazole Sodium | Pantoprazole Sodium | 547 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 541 | 121 |
| Meloxicam | Meloxicam | 411 | 108 |
| Lorazepam | Lorazepam | 402 | 51 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 358 | 83 |
| Gabapentin | Gabapentin | 344 | 50 |
| Furosemide | Furosemide | 319 | 76 |
| Lisinopril | Lisinopril | 306 | 70 |
| Sertraline Hcl | Sertraline Hcl | 280 | 45 |
| Simvastatin | Simvastatin | 277 | 60 |
| Omeprazole | Omeprazole | 263 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 250 | 58 |
| Metformin Hcl | Metformin Hcl | 243 | 51 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 223 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 222 | 56 |
| Tramadol Hcl | Tramadol Hcl | 219 | 28 |
| Potassium Chloride | Potassium Chloride | 194 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 182 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 182 | 40 |
| Cephalexin | Cephalexin | 180 | 117 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 179 | 51 |
| Metformin Hcl Er | Metformin Hcl | 173 | 43 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 170 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 158 | 36 |
| Citalopram Hbr | Citalopram Hydrobromide | 157 | 27 |
| Allopurinol | Allopurinol | 142 | 32 |
| Temazepam | Temazepam | 140 | 17 |
| Alprazolam | Alprazolam | 139 | 17 |
| Glimepiride | Glimepiride | 138 | 24 |
| Donepezil Hcl | Donepezil Hcl | 136 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 136 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 134 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 131 | 31 |
| Prednisone | Prednisone | 129 | 88 |
| Trazodone Hcl | Trazodone Hcl | 128 | 22 |
| Synthroid | Levothyroxine Sodium | 126 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 124 | 19 |
| Clonidine Hcl | Clonidine Hcl | 120 | 22 |
| Cefdinir | Cefdinir | 119 | 91 |
| Eliquis | Apixaban | 119 | 21 |
| Azithromycin | Azithromycin | 118 | 91 |
| Pravastatin Sodium | Pravastatin Sodium | 115 | 29 |
| Estradiol | Estradiol | 105 | 21 |
| Warfarin Sodium | Warfarin Sodium | 103 | suppressed |
| Bumetanide | Bumetanide | 101 | 22 |
| Telmisartan | Telmisartan | 101 | 25 |
| Oxybutynin Chloride | Oxybutynin Chloride | 99 | 18 |
| Diazepam | Diazepam | 98 | 16 |
| Dicyclomine Hcl | Dicyclomine Hcl | 97 | 23 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 97 | 48 |
| Carvedilol | Carvedilol | 95 | 18 |
| Sucralfate | Sucralfate | 88 | 21 |
| Jardiance | Empagliflozin | 85 | 14 |
| Ezetimibe | Ezetimibe | 82 | 19 |
| Methocarbamol | Methocarbamol | 82 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 82 | 61 |
| Glipizide | Glipizide | 80 | 23 |
| Atenolol | Atenolol | 79 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 78 | 15 |
| Pregabalin | Pregabalin | 78 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 76 | 43 |
| Oxycodone Hcl | Oxycodone Hcl | 76 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 71 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 70 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 68 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 68 | suppressed |
| Celecoxib | Celecoxib | 67 | suppressed |
| Baclofen | Baclofen | 61 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 61 | suppressed |
| Ozempic | Semaglutide | 60 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 59 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 15 |
| Promethazine Hcl | Promethazine Hcl | 59 | suppressed |
| Mupirocin | Mupirocin | 57 | 37 |
| Clonazepam | Clonazepam | 56 | suppressed |
| Novolog Flexpen | Insulin Aspart | 55 | 14 |
| Methadone Hcl | Methadone Hcl | 53 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 32 |
| Famotidine | Famotidine | 48 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 47 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 46 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Mounjaro | Tirzepatide | 46 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 44 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 42 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | suppressed |
| Primidone | Primidone | 41 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | suppressed |
| Fluconazole | Fluconazole | 39 | 20 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Mirtazapine | Mirtazapine | 39 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 35 | 13 |
| Amoxicillin | Amoxicillin | 34 | 21 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 33 | 12 |
| Glipizide Er | Glipizide | 33 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 32 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 32 | suppressed |
| Verapamil Er | Verapamil Hcl | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Acyclovir | Acyclovir | 27 | 13 |
| Ibuprofen | Ibuprofen | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 25 | 25 |
| Sulindac | Sulindac | 25 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 24 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Ondansetron Odt | Ondansetron | 24 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 23 | 23 |
| Carisoprodol | Carisoprodol | 23 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 22 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Fentanyl | Fentanyl | 21 | suppressed |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 16 |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Haloperidol | Haloperidol | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Carbamazepine Er | Carbamazepine | 19 | suppressed |
| Sotalol | Sotalol Hcl | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 13 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | 12 |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Verapamil Sr | Verapamil Hcl | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 13 | suppressed |
| Ingrezza | Valbenazine Tosylate | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Misoprostol | Misoprostol | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $78.45 · 5 records | Amgen Inc. | Kerendia, OTEZLA, REPATHA, REXULTI, ROXYBOND | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error